Trump threatens 100% tariff on US drug makers that don’t strike deals to lower prices

President Trump is threatening 100% tariffs on pharmaceutical companies that refuse to negotiate lower prices for US drugs. The tariff would apply only to branded drugs and their active ingredients, while exempting generic drugs for at least one year. This move represents Trump's effort to use tariff leverage to pressure drug makers into price negotiations, a central part of his administration's drug pricing agenda. Generic drugs, which represent the majority of prescriptions filled in the US, would avoid the tariff initially, potentially creating incentives for branded drugmakers to accept deals. The threat marks an escalation in Trump's broader strategy to reduce pharmaceutical costs through executive action.